Replicate Design [Two-Stage / GS Designs]

posted by Naveen Kumar – India, 2014-06-23 15:19 (4017 d 10:33 ago) – Posting: # 13124
Views: 6,557

Dear All,

Please suggest, can we design full replicate bioequivalence study (molecule is highly variable) in stages for EMEA submission.

My concern is Power will play pivotal role in stage design, which not be in replicate (full) designs.

Regards,
Naveen Kumar.SR


Edit: Category and subject line changed. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,674 registered users;
16 visitors (0 registered, 16 guests [including 11 identified bots]).
Forum time: 01:53 CEST (Europe/Vienna)

Medical researches can be divided into two sorts:
those who think that meta is better and those
who believe that pooling is fooling.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5